277 - 288 of 7601 results
0.75 CME CREDIT

This engaging session will review risk factors for falls and the approach to treating a patient who has fallen or is at high risk of falling. Participants will learn about guidelines and validated tools for gait and fall risk assessment and review evidence-based interventions that have been shown to prevent falls in community-dwelling older adults.


0.75 CME CREDIT

Memory loss is a common complaint across the age spectrum. This presentation will give a practical and cost-effective approach to assessing memory loss in the primary care setting.


0.75 CME CREDIT

The purpose of this talk is to provide a broad overview of cutaneous malignancies and emphasize the most common types: basal cell carcinomas, squamous cell carcinomas, and malignant melanomas. The speaker will focus on effective screening questions and physical exam clues that guide clinical decision-making and distinguish cases that need immediate referral from those that can be managed in the primary care setting. A portion of the talk will focus on both surgical and non-surgical options for management of cutaneous malignancies. The final segment of the talk will focus on helpful cutaneous clues for diagnosis of internal malignancies.


1 CME CREDIT

Knee pain is one of the most common musculoskeletal complaints in primary care. This presentation will cover a systematic evidence-based approach to the knee exam. Through live demonstrations and patient cases, you will learn differences between a knee exam focused on acute versus overuse injuries and develop more awareness of pediatric and geriatric considerations.


1 CME CREDIT

This talk will cover recent clinical trials presented at the ADA in 2019 that have an impact on the management of diabetes, such as cardiovascular outcomes trials and the first oral GLP-1 RA phase 3 data. The faculty will take you through the latest guidelines from the ADA regarding the management of type 2 diabetes and describe how recent clinical trial data has been integrated in to these guidelines. After this meeting review, you will be equipped to manage type 2 diabetes based on these guidelines.


0.75 CME CREDIT

This talk will provide an overview of the evaluation and management of patients with osteoporosis. Current screening guidelines and diagnostic criteria for osteoporosis will be reviewed. Risk factors for osteoporosis will be identified. The evaluation of patients with osteoporosis will be discussed. Data will be provided on treatment options for osteoporosis as well as the risks and benefits of treatment.


0.75 CME CREDIT

Patients interested in contraceptives can now select from a wide array of effective methods. This lecture will provide an overview of commonly-prescribed reversible contraceptive methods and current issues pertaining to their use.


0.75 CME CREDIT

This case-based talk will review common challenges and situations that both neurologists and primary care clinicians face in caring for patients with movement disorders. Movement disorders can be divided into hypokinetic (reduced and slowed movements) and hyperkinetic (excessive and quick movements), and the faculty will provide a framework to recognize them. Participants will learn about movement disorder assessment, treatment challenges, and explore new options in both essential tremor and in Parkinson’s disease. Lastly, the faculty will contextualize Parkinson’s disease, along with Lewy Body Dementia, in the spectrum of neurodegenerative conditions.


0.75 CME CREDIT

Post-Traumatic Stress Disorder (PTSD) has been associated with multiple physical symptoms, chronic medical conditions, and excess healthcare utilization. Despite its prevalence, rates of timely and accurate recognition are alarmingly low, and misdiagnosis is common. In primary care, undiagnosed and unmanaged PTSD has a substantial deleterious impact on physical health status. This presentation will discuss: (1) common physical manifestations of PTSD, particularly how PTSD might present for various demographic subgroups and with less obvious signs; (2) evidence demonstrating how accurate identification of PTSD and implementing protocols for trauma-informed care lead to improved patient engagement and wellbeing; and (3) suggestions for providing evidence supported trauma-informed primary care, including pharmacotherapy, brief psychoeducational interventions, and referrals that maximize patient engagement.


1 CME CREDIT

Adolescence is a period of tremendous growth and development, not only physically but emotionally and psychosocially. Understanding the health care issues unique to adolescents and how to best approach these issues will benefit both the health care provider and the adolescent patient. We will look at cases that highlight some problems that primary care providers may encounter in their practices.


0.75 CME CREDIT

Asthma in children is all too often not well controlled. It remains one of the most common chronic illnesses you will manage in your office and one of the most frequent reasons why children are admitted to the hospital. I will discuss recent updates on managing asthma exacerbations with inhaled and oral steroids including the risks and benefits of dexamethasone. In addition, I will review the safety of using long-acting beta agonists in combination with inhaled steroids in children. I will also provide recommendations on when to consider treatment with omalizumab, one of the new asthma biological therapies, which has been approved for children as young as six years of age.


0.75 CME CREDIT

This session will focus on the diagnosis and treatment of asthma in the ambulatory setting, with an emphasis on new developments in the last year. It will cover: measurement of exhaled nitric oxide in the diagnosis and assessment of asthma, safety of long-acting beta-agonists in the treatment of asthma, use of long-acting anticholinergic bronchodilators for asthma, and novel biologic therapies for asthma. We will also review teaching the use of inhalers in asthma, including metered-dose inhalers, dry-powder inhalers, breath-actuated inhalers, and soft-mist inhalers.